Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 81INDUSTRY 52OTHER_GOV 4NETWORK 3NIH 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Head and Neck Neoplasms 5Neoplasms 2Deglutition Disorders 2Respiratory Aspiration 1Recurrence 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Esophageal Stenosis 1Carcinoma, Squamous Cell 1Bites and Stings 1

Interventions

Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Recurrence × Head & Neck × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡